On Episode 32 of The HQ Podcast, we’re pleased to be joined by Dr. Christopher McCabe, Professor of Health Economics at Queens University in Belfast, Northern Ireland, and renowned health economics leader. During our conversation, we discuss the notion of “value” as it relates to healthcare (what it is, why it’s important, how we measure it) and the crucial questions that need to be asked when it comes to designing or re-building a healthcare system that not only produces the best outcomes for taxpayers but also considers the critical health professionals who ultimately will deliver the healthcare priorities that Canadians need to agree upon.
Tune in for an engaging and thought-provoking conversation that will leave you with a deeper understanding of healthcare economics, value and the questions we need to ask to rebuild a better healthcare system.
About Chris McCabe
Dr Christopher McCabe is Professor of Health Economics at Queens University Belfast, jointly appointed to the Faculty of Medicine, Health and Life Sciences and Queens Management School. He was previously the CEO and Executive Director of the Institute of Health Economics, a not-for-profit research institute in Alberta Canada.
Dr McCabe has 30 years’ experience as a university based health economist. He trained and worked for 20 years in the UK before emigrating to Canada. His PhD was concerned with the methods for valuing paediatric health. During his time in the UK, he held Full Professorships at the Universities of Sheffield, Warwick and Leeds. In the United Kingdom he was the founding Director of both the NICE Decision Support Unit, and the Academic Unit of Health Economics at the University of Leeds. He was more recently a Professor of Health Economics at the University of Alberta, where he was appointed to the Capital Health Endowed Research Chair.
Dr McCabe has contributed to a number of standard setting documents related to the evaluation of innovative health technologies including the second edition of the NICE Guide to the Methods of Health Technology Appraisal, the fourth edition of the CADTH Guidelines for the Economic Evaluation of Health Technologies, and third edition of the ISSC Guidelines for the translation of stem cell research and regenerative medicine. He was lead author of the 2018 CADTH Guideline on the economic evaluation of co-dependent therapies. He has contributed key papers to the literature the reimbursement of treatments for rare diseases. More recently Dr. McCabe advised the Patented Medicines Price Review Board on the technical issues related to the revision of their regulations for setting the price of patented drugs in Canada. He is currently Chair of the Royal Society of Canada COVID Task Force Working Group on the Economy, and a member of the same task force’s Working Group on Health Care post-COVID.
Chris McCabe | LinkedIn: Click Here
Tell Us What You Think
We welcome your feedback about the HQ Podcast so we can continuously improve and create episodes that our listeners want to hear.
Please take a few moments to fill out our short survey: Click Here
Don’t forget to subscribe to The HQ on your favourite podcast player and leave us a review!